阿洛普雷格纳诺及其对抗剂调节神经炎症和神经功能障碍
Torbjörn Bäckström1, Magnus Doverskog2, Thomas P Blackburn2
1Department of Clinical Sciences, University of Umeå, Sweden.
Neuroscience and biobehavioral reviews
|April 12, 2024
概括
神经类固醇通过影响微质细胞和星球细胞来调节神经炎症. 特殊的化合物,如阿洛普雷格纳诺和戈列克萨诺显示出在正常化脑细胞功能治疗中枢神经系统和肝脏疾病的潜力.
科学领域:
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 神经炎症是各种脑部疾病的关键因素.
- 神经类固醇,作为积极的类固醇性GABA-A受体调节剂 (类固醇-PAM),影响神经炎症.
- 类固醇-PAM水平由局部生产和全身循环调节,受TSPO表达和酶活性等因素的影响.
研究的目的:
- 审查类固醇-PAMs在神经炎症中的作用.
- 探索类固醇-PAMs在中枢神经系统和肝脏疾病中的治疗潜力.
主要方法:
- 文献综述侧重于神经类固醇,神经炎症和GABA-A受体.
- 对类固醇-PAMs和相关化合物影响质细胞 (微细胞和星体细胞) 的机制的分析.
主要成果:
- 类固醇PAM和GABA可以调节微质细胞和星球细胞的激活.
- 阿洛普雷格纳诺 (一种类固醇-PAM) 和戈列克萨诺 (一种新型GABA-A受体调节类固醇对手 - - GAMSA) 抑制微质细胞和星球细胞的激活.
- 这些化合物可以使质细胞功能正常化.
结论:
- 类固醇-PAMs在调节神经炎症方面发挥着重要作用.
- 阿洛普雷格纳诺和戈列克萨诺显示出作为神经炎症疾病治疗剂的潜力.
- 对这些化合物的进一步研究可能会导致中枢神经系统和肝脏疾病的新治疗方法.
相关概念视频
Ligand-Gated Ion Channel Receptor: Gating Mechanism
2.2K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.2K
Alzheimer's Disease: Overview
468
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
468
Drugs Affecting Neurotransmitter Synthesis
1.4K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.4K
Neural Regulation
39.4K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.4K
Neurochemical Transmission: Sites of Drug Action
2.3K
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
2.3K
Alzheimer's Disease: Treatment
183
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
183


